Retension Pharmaceuticals, Inc. — Form D
Retension Pharmaceuticals, Inc. of MCLEAN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-06. The offering totals $20.0M, of which $12.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-05-06
- Form: D
- Accession: 0002002988-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $12.3M
- Remaining: $7.7M
- Investors: 98
- Date of first sale: 2025-04-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-545343
Issuer
- Name: Retension Pharmaceuticals, Inc.
- CIK: 0002002988
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O REDUX THERAPEUTICS, LLC, MCLEAN, VA, 22101
- Phone: (703) 624-2024
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael Berendt | Director | McLean, VA |
| Eric Keller | Director | McLean, VA |
| Donald Olds | Director | McLean, VA |
| Eric Keller | Executive Officer | McLean, VA |
Other filings by this issuer (2)
More